Pre-market mover: C8R.SI Jiutian Chemical (SES) S$0.024 06 Feb 2026: watch volume

Jiutian Chemical’s C8R.SI stock trades at S$0.024 pre-market on 06 Feb 2026, up 4.35% on volume of 364,900.00 shares. This move places the Catalist-listed Jiutian Chemical Group Limited (SES) among high-volume movers in Singapore. The spike follows thin average liquidity and wide trading ranges, so short-term momentum will hinge on whether average volume of 1,308,503.00 shares resurfaces. We review fundamentals, technicals, Meyka grade and a model forecast to help size risk and opportunity.

Pre-market price and volume snapshot for C8R.SI stock

Jiutian Chemical (C8R.SI) is at S$0.024, up 4.35% from the prior close of S$0.023. The session shows 364,900.00 shares traded versus an average volume of 1,308,503.00, giving a relative volume of 2.66. One claim: the trade is liquidity-driven rather than news-driven, as no new corporate release accompanies this pre-market activity. Check official filings and the upcoming earnings date on 2026-03-04 for confirmation.

Why volume matters to C8R.SI stock momentum

High volume can validate a price move; here the spike to 364,900.00 shares suggests institutional or block activity. One claim: if daily volume sustains above 1,000,000.00, moves toward the year high of S$0.032 become technically possible. Conversely, low follow-through volume increases the risk of a quick fade back toward the year low of S$0.021.

Fundamentals and recent financials for C8R.SI stock

One claim: Jiutian Chemical’s FY2024 results show sharp revenue compression and continued losses. Revenue fell to S$50.57 million in 2024 from S$598.56 million in 2023, and net losses narrowed to S$147.90 million. Key metrics: EPS -0.01, PE -2.30, and market cap S$45,734,212.00. Balance-sheet strengths include cash per share S$0.20 and a current ratio of 1.92, but margin ratios are negative and ROE is -21.36%, indicating recovery is incomplete.

Technical indicators and liquidity signals for C8R.SI stock

One claim: the technical picture is mixed but watchable. Momentum indicators show RSI 44.75 and ADX 30.06 indicating a developing trend. Price sits below the 50-day average of S$0.0253 and 200-day average of S$0.02579, so resistance is clear near short-term moving averages. Use stop management given the wide cash conversion cycle of 113.21 days and thin average trading depth on Catalist.

Meyka AI rates C8R.SI with a score out of 100 and model forecast

Meyka AI rates C8R.SI with a score out of 100. Score: 60.61 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. One claim: the grade reflects a mixed outlook — measurable assets and recovered cash flow trends against weak margins.

Meyka AI’s forecast model projects a yearly price of S$0.02889, implying an upside of 20.47% versus the current S$0.024. Forecasts are model-based projections and not guarantees.

Risks and catalysts shaping C8R.SI stock outlook

One claim: the largest near-term catalysts are the earnings announcement on 2026-03-04 and any update on production volumes for DMF and methylamine. Risks include continued weak margins, inventory and receivables pressure (days sales outstanding 130.29), and low free cash flow per share of -0.09. Sector context: basic materials in Singapore has modest liquidity compared with larger industries, so market moves can be amplified.

Final Thoughts

Key takeaways for C8R.SI stock: the pre-market rise to S$0.024 on 06 Feb 2026 reflects high-volume activity but not yet a confirmed trend. Fundamentals show a recovery in some cash metrics but continued negative profitability with EPS -0.01 and ROE -21.36%. Technicals suggest resistance near S$0.0253 (50-day average) while Meyka AI’s model projects a yearly target of S$0.02889, an implied upside of 20.47% from current levels. For traders, the short-term strategy is volume-confirmed entries with tight risk controls; for investors, wait for clearer margin improvement and post-earnings guidance. Meyka AI provides this as part of our AI-powered market analysis platform; forecasts are model-based and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.